News | March 31, 2023
Evonik starts construction of US$220 million lipid innovation center in Lafayette
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
Brexpiprazole Tablets, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, and 4 mg, (RLD Rexulti) had estimated annual sales of US $1,575 million in the US (IQVIA MAT December 2022)
The antiviral is efficacious in non-human primates, and is safe and well-tolerated in humans
ELL will be the preferred source of supply for some the key Raw Materials to VPPL at "Arm's Length" transaction.
KRIVIDA TRIVUS detects the specific virus causing a respiratory infection.
Dr. Hubbard brings more than 35 years of experience in the biopharmaceutical and pharma-tech services industries and CROs.
The Development Center with its state-of-the art laboratories and flexible pilot capacities is set to become Siegfried's global research and development hub for its Drug Products sites, strengthening the global network
Receives Subject Expert Committee recommendation to bring new therapies of Pompe, ASMD to India
The new Beyfortus data are consistent with all data accumulated to date and confirm its strong profile
The EIR was issued post the last inspection of the facility conducted from October 17, 2022 to October 29, 2022
Subscribe To Our Newsletter & Stay Updated
